SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trustmanic who wrote (97)8/20/1997 8:30:00 PM
From: burner   of 193
 
George,
You probably have not missed NVO. It traded around 1.40 today and may drop further. I do not own any anymore but am consdidering buying back in.
There may be another way to play an NVO buy----they are merging with GPI and GPI shareholders are getting 1.6 shares of NVO for every share of GPI. Shareholder approval has been given and it is now a matter of regulatory approval. If NVO trades at 1.40 then anything below 2.25 for GPI is a bargain---if the compananies maintain these levels.
NVO will undoubtedly be a solid, perhaps blue chip, stock someday in the not too distant future. The parent company is showing more respect for their offspring and someday may decide they would like to have that TSE listing for some public financing (IMHO).
Regards,
Dan
P.S. Helix should show some renewed signs of life soon. They seem to have the expertise but I am not convinced that their PR is generating much response in the investment community.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext